Atlas Trials

Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old

Clinical trial NCT00439660 · COMPLETED

Trial details

NCT number
NCT00439660
Sponsor
Bharat Biotech International Limited
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Diarrhea
Start date
2006-12-01
Primary completion
2008-11-01
Enrollment
540

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.